Carmot is
applying an innovative
technology, Chemotype Evolution, to overcome the limitations of conventional discovery
technologies and identify
superior drug candidates for challenging therapeutic targets.
Carmot is
applying a transformative
technology, Chemotype Evolution, to overcome the limitations of conventional discovery
technologies and to identify
superior drug candidates for challenging therapeutic targets.
Applying Nissenbaum's model to court records would thus entail a careful consideration of a variety of contexts in which those records are generated, the rejection of certain new information
technologies, and also negotiations with technologists to determine whether certain new
technologies, or the data they process, could be modified so as to render those
technologies superior to the original systems in vindicating general and contextual values.